AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11400999 — intervention group
Group type: COMPARATOR
Intervention: Control session (no TD)
Number of subjects: 10
Study 9389807 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/d P vaginally
Number of subjects: 20
Study 9389807 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/d P vaginally
Number of subjects: 20
Study 9389807 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/d P vaginally
Number of subjects: 20
Study 7898010 — intervention group
Group type: EXPERIMENTAL
Intervention: T-activin
Number of subjects: 105
Study 3229874 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine, 2 g/day for three months
Number of subjects: 30
Study 3229874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29334645 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-threshold depressive disorder (n = 24)
Number of subjects: 82
Study 29334645 — intervention group
Group type: COMPARATOR
Intervention: No full-threshold depressive disorder
Number of subjects: 82
Study 27007753 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative Light‐induced Fluorescence‐Digital (QLF) images
Number of subjects: 33
Study 27007753 — intervention group
Group type: COMPARATOR
Intervention: White light (WL)
Number of subjects: 33
Study 24297579 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelets 24 hours after recombinant tissue plasminogen activator (group A)
Number of subjects: 146
Study 24297579 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelets for patients without SWI-visualised haemorrhage (group B)
Number of subjects: 146
Study 24297579 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups A and B
Number of subjects: 146
Study 23448854 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL)
Number of subjects: 69
Study 23448854 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 69
Study 23448854 — intervention group
Group type: COMPARATOR
Intervention: Pediatric residents (PED)
Number of subjects: 69
Study 23448854 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency medicine residents (EM)
Number of subjects: 69
Study 21122200 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 157
Study 21122200 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 157
Study 21122200 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin and Aspirin
Number of subjects: 157
Study 18055141 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine dry powder inhaler (12.5 to 200 microg per metered dose)
Number of subjects: 18
Study 18055141 — intervention group
Group type: COMPARATOR
Intervention: Methacholine solution
Number of subjects: 18
Study 15781524 — intervention group
Group type: COMPARATOR
Intervention: 5 mg single-dose extended-release epidural morphine (EREM)
Number of subjects: 541
Study 15781524 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg single-dose EREM
Number of subjects: 541
Study 15781524 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg single-dose EREM
Number of subjects: 541
Study 15781524 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg single-dose EREM
Number of subjects: 541
Study 15781524 — intervention group
Group type: COMPARATOR
Intervention: 5 mg standard epidural morphine sulfate (MS)
Number of subjects: 541
Study 15781524 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose EREM (all doses)
Number of subjects: 541
Study 15781524 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose EREM (15, 20, and 25 mg)
Number of subjects: 541
Study 12841924 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine (AZE)
Number of subjects: 144
Study 12841924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 144
Study 12841924 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 144
Study 10900559 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (SSRI)
Number of subjects: 33
Study 10900559 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 33
Study 10900559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 8644802 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (pars plana vitrectomy with C3F8 injection and face-down positioning for two weeks)
Number of subjects: 36
Study 8644802 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 36
Study 8644802 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 36
Study 8644802 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 36
Study 1440484 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose heparin plus dihydroergotamine (DHE; 0.5 mg, given 8 hourly by sc injection)
Number of subjects: 117
Study 1440484 — intervention group
Group type: COMPARATOR
Intervention: Low dose heparin alone (5,000 IU sodium heparin given subcutaneously [sc] 8 hourly until the seventh postoperative day)
Number of subjects: 117
Study 3553478 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-reduction intervention
Number of subjects: 131
Study 3553478 — intervention group
Group type: COMPARATOR
Intervention: No-diet intervention (Control)
Number of subjects: 131
Study 28419624 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine 10 mg
Number of subjects: 29
Study 28419624 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg
Number of subjects: 29
Study 28419624 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine 12 mg
Number of subjects: 29
Study 28419624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 27400948 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan 60 mg/m² on days 1, 8, and 15 plus cisplatin 60 mg/m² on day 1 (CPT-P group) every 4 weeks for six cycles
Number of subjects: 667
Study 27400948 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 175 mg/m² plus carboplatin AUC 6.0 mg/mL/min on day 1 (TC group) every 3 weeks for six cycles
Number of subjects: 667
Study 27400948 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan plus cisplatin (CPT-P group)
Number of subjects: 667
Study 27400948 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel plus carboplatin (TC group)
Number of subjects: 667
Study 25929209 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered implant set
Number of subjects: 0
Study 25929209 — intervention group
Group type: COMPARATOR
Intervention: Uncovered implant set
Number of subjects: 0
Study 24124358 — intervention group
Group type: EXPERIMENTAL
Intervention: salmeterol/fluticasone propionate (SFC) 50/250 μg twice daily
Number of subjects: 400
Study 24124358 — intervention group
Group type: COMPARATOR
Intervention: tiotropium bromide 18 μg once daily
Number of subjects: 400
Study 24124358 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIPLE therapy (SFC twice daily and tiotropium once daily)
Number of subjects: 400
Study 20377577 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiretroviral therapy
Number of subjects: 0
Study 20377577 — intervention group
Group type: COMPARATOR
Intervention: Single drug regimen
Number of subjects: 0
Study 18333706 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone Care Coordination Program (including simple 2‐click referral, proactive care coordination, medication management, and 5 follow‐up telephone calls)
Number of subjects: 2965
Study 18333706 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2965
Study 17028466 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment of patients with HELLP syndrome
Number of subjects: 0
Study 17028466 — intervention group
Group type: COMPARATOR
Intervention: Prompt delivery
Number of subjects: 0
Study 14711132 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological interventions (chemical agents)
Number of subjects: 0
Study 14711132 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral/psychosocial interventions (manual-guided therapy)
Number of subjects: 0
Study 14711132 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment services
Number of subjects: 0
Study 10890339 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture + mobilization
Number of subjects: 60
Study 10890339 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear acupuncture + mobilization
Number of subjects: 60
Study 10890339 — intervention group
Group type: COMPARATOR
Intervention: Mobilization alone (control)
Number of subjects: 60
Study 8818503 — intervention group
Group type: EXPERIMENTAL
Intervention: Le Nez du Vin smell test
Number of subjects: 132
Study 8818503 — intervention group
Group type: COMPARATOR
Intervention: University of Pennsylvania Smell Identification Test (UPSIT)
Number of subjects: 132
Study 1581404 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional maintenance therapy
Number of subjects: 448
Study 1581404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive postconsolidation therapy
Number of subjects: 448
Study 1581404 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 448
Study 3878682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's lactate
Number of subjects: 19
Study 3878682 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 19
Study 31314957 — intervention group
Group type: EXPERIMENTAL
Intervention: sLV5FU2 group
Number of subjects: 114
Study 31314957 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine group
Number of subjects: 114
Study 29419653 — intervention group
Group type: EXPERIMENTAL
Intervention: Naldemedine 0.2 mg once daily
Number of subjects: 623
Study 27457913 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Periodization (TP)
Number of subjects: 11
Study 27457913 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Undulating Periodization (DUP)
Number of subjects: 11
Study 27457913 — intervention group
Group type: COMPARATOR
Intervention: Control (Washout Period)
Number of subjects: 11
Study 24385033 — intervention group
Group type: EXPERIMENTAL
Intervention: External rotation brace (n = 31)
Number of subjects: 60
Study 24385033 — intervention group
Group type: COMPARATOR
Intervention: Internal rotation sling (n = 29)
Number of subjects: 60
Study 22294668 — intervention group
Group type: EXPERIMENTAL
Intervention: Hartmann's and 5% dextrose at full maintenance rate
Number of subjects: 82
Study 22294668 — intervention group
Group type: COMPARATOR
Intervention: 0.45% saline and 5% dextrose at two-thirds maintenance rate
Number of subjects: 82
Study 19940437 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 274
Study 17631074 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 160 mg
Number of subjects: 404
Study 17631074 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg plus Simvastatin 20 mg
Number of subjects: 404
Study 17631074 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg plus Simvastatin 80 mg
Number of subjects: 404
Study 16133688 — intervention group
Group type: COMPARATOR
Intervention: ALN 5 mg once daily
Number of subjects: 328
Study 16133688 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN 35 mg once weekly
Number of subjects: 328
Study 11845375 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg droperidol
Number of subjects: 120
Study 11845375 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 120
Study 11845375 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 ml NaCl 0.9%)
Number of subjects: 120
Study 11845375 — intervention group
Group type: EXPERIMENTAL
Intervention: Quintuple prophylaxis (10 mg metoclopramide, 2.5 mg droperidol, 12.5 mg dolasetron, 62.5 mg dimenhydrinate, 8 mg dexamethasone)
Number of subjects: 120
Study 11072390 — intervention group
Group type: EXPERIMENTAL
Intervention: Persuasive simulated radio message on the risks of Light cigarettes
Number of subjects: 568
Study 7669374 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine infusion (loading dose of 100 micrograms/kg over 30 min followed by continuous infusion at 10 micrograms/kg per hour)
Number of subjects: 26
Study 7669374 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine infusion
Number of subjects: 26
Study 1735983 — intervention group
Group type: EXPERIMENTAL
Intervention: University of Wisconsin solution (UWS)
Number of subjects: 42
Study 1735983 — intervention group
Group type: COMPARATOR
Intervention: Conventional preservation using crystalloid cardioplegia and saline storage (CCS)
Number of subjects: 42
Study 6704504 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation A
Number of subjects: 5
Study 6704504 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation B
Number of subjects: 5
Study 6704504 — intervention group
Group type: COMPARATOR
Intervention: Formulation A and B
Number of subjects: 5
Study 6704504 — intervention group
Group type: COMPARATOR
Intervention: RIA and GC‐MS
Number of subjects: 5
Study 31068161 — intervention group
Group type: EXPERIMENTAL
Intervention: AIMS interventions (Unit‐based Physician Teams, Unit Nurse‐Physician Co‐leadership, Enhanced Interprofessional Rounds, Unit‐level Performance Reports, Patient Engagement Activities)
Number of subjects: 0
Study 31068161 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 29954454 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium adolescentis IVS‐1
Number of subjects: 0
Study 29954454 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactooligosaccharides (GOS)
Number of subjects: 0
Study 29954454 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis BB‐12
Number of subjects: 0
Study 29954454 — intervention group
Group type: EXPERIMENTAL
Intervention: GOS
Number of subjects: 0
Study 29954454 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium adolescentis IVS‐1 + GOS
Number of subjects: 0
Study 26912209 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol 500/20 μg (high dose)
Number of subjects: 62
Study 26912209 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol 100/10 μg (low dose)
Number of subjects: 62
Study 26912209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 23344106 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone (400 mg bid)
Number of subjects: 4628
Study 23344106 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 4628
Study 23344106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4628
Study 23059576 — intervention group
Group type: EXPERIMENTAL
Intervention: UT-e (ultrasound etched)
Number of subjects: 16
Study 23059576 — intervention group
Group type: EXPERIMENTAL
Intervention: DB-e (diamond burs etched)
Number of subjects: 16
Study 23059576 — intervention group
Group type: EXPERIMENTAL
Intervention: UT-n/e (ultrasound non-etched)
Number of subjects: 16
Study 23059576 — intervention group
Group type: EXPERIMENTAL
Intervention: DB-n/e (diamond burs non-etched)
Number of subjects: 16
Study 19960350 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual endurance training combined with heavy strength training (E + S)
Number of subjects: 20
Study 19960350 — intervention group
Group type: COMPARATOR
Intervention: Usual endurance training only (E)
Number of subjects: 20
Study 17401014 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate during pelvic radiotherapy
Number of subjects: 0
Study 17401014 — intervention group
Group type: COMPARATOR
Intervention: Pelvic radiotherapy without sucralfate (control group not explicitly mentioned)
Number of subjects: 0
Study 16293780 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week program of group sessions (1.5 hours per week) offering social support and education
Number of subjects: 116
Study 16293780 — intervention group
Group type: COMPARATOR
Intervention: Standard list of community resources and option to participate in group sessions at the end of follow-up
Number of subjects: 116
Study 11897643 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (CPAP) for 8 weeks
Number of subjects: 42
Study 11897643 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet for 8 weeks
Number of subjects: 42
Study 11897643 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal CPAP
Number of subjects: 42
Study 10193670 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril 20 mg alone
Number of subjects: 12
Study 10193670 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril 20 mg with propranolol 80 mg
Number of subjects: 12
Study 10193670 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril 20 mg alone
Number of subjects: 12
Study 10193670 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril 20 mg with propranolol 80 mg
Number of subjects: 12
Study 7773825 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic home visit
Number of subjects: 141
Study 2268940 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaobu Jianfei Pian (XJP)
Number of subjects: 51
Study 2268940 — intervention group
Group type: COMPARATOR
Intervention: Fangfeng Tongsheng San
Number of subjects: 51
Study 7040142 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet advice
Number of subjects: 0
Study 7040142 — intervention group
Group type: COMPARATOR
Intervention: Low carbohydrate diet advice
Number of subjects: 0
Study 31433259 — intervention group
Group type: EXPERIMENTAL
Intervention: ReSound Assist (app-based communication)
Number of subjects: 30
Study 31433259 — intervention group
Group type: COMPARATOR
Intervention: In-person follow-up appointments (control)
Number of subjects: 30
Study 30056586 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT 60 J/arm
Number of subjects: 15
Study 30056586 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT 90 J/arm
Number of subjects: 15
Study 30056586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30056586 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT 120 J/arm
Number of subjects: 15
Study 28756267 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 100 to 200 mg twice daily
Number of subjects: 24081
Study 28756267 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 375 to 500 mg twice daily
Number of subjects: 24081
Study 28756267 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 to 800 mg thrice daily
Number of subjects: 24081
Study 27544988 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel well-padded new fighting vest (NFV)
Number of subjects: 243
Study 27544988 — intervention group
Group type: COMPARATOR
Intervention: Standard unisex special unit fighting vest (SUFV)
Number of subjects: 243
Study 25115428 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed-dye laser
Number of subjects: 147
Study 25115428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 147
Study 23114559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 12-week strength-power training, twice a week, supervised by a physiotherapist
Number of subjects: 46
Study 23114559 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 46
Study 19460849 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD/R plus ATP pacing
Number of subjects: 71
Study 19460849 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD/R plus ATP and prevention pacing
Number of subjects: 71
Study 19460849 — intervention group
Group type: COMPARATOR
Intervention: DDD/R pacing
Number of subjects: 71
Study 17259833 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose sodium phosphate (45 mL)
Number of subjects: 100
Study 17259833 — intervention group
Group type: COMPARATOR
Intervention: Double-dose sodium phosphate (90 mL)
Number of subjects: 100
Study 15177699 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH treatment for 3 and 6 months
Number of subjects: 18
Study 15177699 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH treatment for 6 months
Number of subjects: 18
Study 15177699 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 3 and 6 months
Number of subjects: 18
Study 15177699 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH treatment in the open-label phase
Number of subjects: 18
Study 15177699 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment in the open-label phase
Number of subjects: 18
Study 15177699 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH treatment
Number of subjects: 18
Study 15177699 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18
Study 11165820 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 10
Study 11165820 — intervention group
Group type: COMPARATOR
Intervention: Carbopol
Number of subjects: 10
Study 11165820 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate
Number of subjects: 10
Study 9488585 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation with beta-carotene and alpha-tocopherol
Number of subjects: 22
Study 9488585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7999599 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment 50 micrograms/g twice daily
Number of subjects: 30
Study 7999599 — intervention group
Group type: COMPARATOR
Intervention: Coal tar solution BP 15% v/w in aqueous cream applied in the evening
Number of subjects: 30
Study 7999599 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment
Number of subjects: 30
Study 7999599 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment and Coal tar solution
Number of subjects: 30
Study 3263379 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg prednisone
Number of subjects: 15
Study 3263379 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg prednisone
Number of subjects: 15
Study 3263379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29615028 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multicomponent exercise programme (resistance training combined with balance training)
Number of subjects: 150
Study 29615028 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 28465127 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted hand‐washing/surface cleaning intervention
Number of subjects: 10
Study 28465127 — intervention group
Group type: COMPARATOR
Intervention: Control NHs
Number of subjects: 10